Get started
Author

Tuba Baydas

Breast Cancer Patients with Brain Metastases: A Cross-Sectional Study
2022 · Melih Simsek, Altay Aliyev, et al. · The Breast Journal · 22
PDF
Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer
2019 · H. Mehmet Turk, Altay Aliyev, et al. · Current Problems in Cancer · 4
Case Report: Immune checkpoint inhibitor–triggered anti-Ma2 paraneoplastic encephalitis in sarcomatoid pleural mesothelioma: a fatal case
2026 · Ilker Nihat Okten, Tuba Baydaş · Frontiers in Oncology · 3
PDF
Breast cancer surgery in the era of genetic uncertainty: real-world outcomes in BRCA1/2 pathogenic variants and variants of uncertain significance
2026 · Ilker Nihat Ökten, Tuba Baydaş, et al. · BMC Cancer · 2
Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study
2026 · İlker Nihat Ökten, Tuba Baydaş, et al. · Journal of Clinical Medicine · 1
PDF
The prognostic value of tumor budding in gastric adenocarcinomas: A cross-sectional study
2023 · Tuba Baydas, Ganime Coban, et al. · International Journal of Gastrointestinal Intervention · 1
PDF
Fibrolamellar Carcinoma in the Molecular Era: From DNAJB1::PRKACA Biology to Precision Therapeutic Strategies
2026 · Tuba Baydaş, İlker Nihat Ökten · Journal of Gastrointestinal Cancer
Pretreatment CONUT Score and Overall Survival in Patients with Metastatic Pancreatic Adenocarcinoma Receiving First-Line Chemotherapy: A Retrospective Cohort Study
2026 · Zeynep Alaca Topcu, Serhat Demirer, et al. · Medicina
Sequential 18F-FDG and 68Ga-FAPI-04 PET/CT in Early Peritoneal Recurrence of Signet-Ring–Component Rectal Adenocarcinoma
2026 · Mehmet Tarık Tatoğlu, Tuba Baydaş, et al. · Clinical Nuclear Medicine
Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study
2026 · Nur Deniz Yildiz, Çağatay Arslan, et al. · Clinics and Practice
Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3–6 Month Relapse Window
2026 · İbrahim Çil, Maral Martin Mıldanoğlu, et al. · Current Oncology
Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study
2026 · Okan Aydin, Zehra Sucuoglu Isleyen, et al. · Scientific Reports
PDF
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
2026 · Mustafa Seyyar, Ali Kalem, et al. · Current Oncology
PDF
Comparison of anthracycline-containing and anthracycline-free neoadjuvant regimens in HER2-positive breast cancer.
2026 · Mahmut Kara, Senar Ebinc, et al. · Journal of Clinical Oncology
Prognostic Impact of Ectopic Fat Deposition Within the Psoas Muscle in Patients with Stage IV Pancreatic Cancer Receiving Systemic Chemotherapy
2026 · İbrahim Çil, İlker Nihat Ökten, et al. · Journal of Clinical Medicine
PDF
Risk Tier, Variant Certainty, and Real-World Care Patterns in Breast Cancer Patients with Germline Alterations in Breast Cancer Susceptibility Genes
2026 · Tuba Baydaş, İlker Nihat Ökten, et al. · Cancers
PDF
Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study
2026 · Sedat Yildirim, Ozlem Nuray Sever, et al. · Clinical Medicine Insights Oncology
Real-world clinical responses to selpercatinib in RET M918T-mutant medullary thyroid carcinoma
2026 · Ilker Nihat Ökten, Tuba Baydaş · Discover Oncology
Determinants of survival after neoadjuvant chemotherapy in resectable gastric cancer: adjuvant dose intensity, radiotherapy, and pathologic response
2026 · Özgecan Dülgar Kaya, Ayberk Bayramgil, et al. · Expert Review of Anticancer Therapy
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
2026 · Mustafa Seyyar, Ali Kalem, et al. · Research Square
PDF
The Prognostic Value of a Composite Score in Predicting Mortality Among Metastatic Castration-resistant Prostate Cancer Patients Treated with Enzalutamide
2026 · İlker Nihat ÖKTEN, Tuba BAYDAŞ, et al. · Journal of Oncological Sciences
PDF
Comparable Access, Different Outcomes: Breast Cancer Survival Among Syrian Refugees and Turkish Patients in Türkiye
2026 · Ilker Nihat Ökten, Tuba Baydaş, et al. · Current Oncology
PDF
Comparison of Anthracycline-Containing and Anthracycline-Free Neoadjuvant Regimens in HER2-Positive Breast Cancer
2026 · Mahmut Kara, Senar Ebinç, et al. · Research Square
PDF
Prognostic Value of CA 19-9 Elimination Rate for Mortality in Metastatic Pancreatic Cancer
2026 · Ilker Ökten, Tuba Baydaş · Annals of Medical Research
Prognostic Value of Nutritional Status and Early Tumor Marker Dynamics in Metastatic Gastric Cancer
2026 · Tuba Baydaş, İlker Nihat Ökten, et al. · Eurasian Journal of Medical Investigation
Works count: 29
Citation count: 33
H-index: 3
I10-index: 1
Year
Topic
Type